Anbio Biotechnology Class A Ordinary Shares Financial Flexibility Index
Anbio Biotechnology Class A Ordinary Shares financial flexibility index. Anbio Biotechnology Class A Ordinary Shares (NNNN) has a Financial Flexibility Index of 0.93x as of December 2024. Free cash flow of $1.60 Million (operating CF $1.60 Million minus capex $1.67) represents 1% of total liabilities ($1.73 Million). See cash generation quality of Anbio Biotechnology Class A Ordinary Sha to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Anbio Biotechnology Class A Ordinary Shares (2021–2025)
Financial flexibility index of Anbio Biotechnology Class A Ordinary Shares from 2021 to 2025. Historical Financial Flexibility Index trend for Anbio Biotechnology Class A Ordinary Shares across 5 annual periods. Check NNNN operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Anbio Biotechnology Class A Ordinary Shares Financial Flexibility Index by Year (2021–2025)
Anbio Biotechnology Class A Ordinary Shares financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for Anbio Biotechnology Class A Ordinary Shares. For the full cash flow conversion analysis, see NNNN cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -76.72x | $-6.74 Million | $-6.74 Million | $87.84K | ▼ -6481.0% |
| 2024 | 1.20x | $2.08 Million | $2.08 Million | $1.73 Million | ▲ +32.9% |
| 2023 | 0.90x | $898.37K | $898.37K | $993.06K | ▼ -71.3% |
| 2022 | 3.15x | $4.45 Million | $4.45 Million | $1.41 Million | ▲ +79.4% |
| 2021 | 1.76x | $4.18 Million | $4.18 Million | $2.38 Million | — |